Benzinga | Nov 4, 2021 07:48AM EDT

Intellia Therapeutics Q3 EPS $(0.97) Misses $(0.84) Estimate, Sales $7.20M Miss $8.66M Estimate

Intellia Therapeutics (NASDAQ:NTLA) reported quarterly losses of $(0.97) per share which missed the analyst consensus estimate of $(0.84) by 15.48 percent. This is a 106.38 percent decrease over losses of $(0.47) per share from the same period last year. The company reported quarterly sales of $7.20 million which missed the analyst consensus estimate of $8.66 million by 16.81 percent. This is a 67.58 percent decrease over sales of $22.22 million the same period last year.